NCT05951166View on ClinicalTrials.gov

Pulmonary Artery DenerVation Clinical Study Using the Gradient Denervation System in Heart Failure Patients With Pulmonary Hypertension

NAActive, not recruitingINTERVENTIONAL
Enrollment

5

Participants

Timeline

Start Date

May 5, 2023

Primary Completion Date

July 31, 2024

Study Completion Date

July 1, 2025

Conditions
Heart Failure Patients With Pulmonary Hypertension
Interventions
DEVICE

Gradient Denervation System

Pulmonary artery denervation (PADN) procedure

Trial Locations (2)

Unknown

Israeli-Georgian Medical Research Clinic Helsicore, Tbilisi

Tbilisi Heart Clinic, Tbilisi

Sponsors
All Listed Sponsors
lead

Gradient Denervation Technologies

INDUSTRY

NCT05951166 - Pulmonary Artery DenerVation Clinical Study Using the Gradient Denervation System in Heart Failure Patients With Pulmonary Hypertension | Biotech Hunter | Biotech Hunter